EUVIMEDEUVIMED entdecken
Open Access

A Natural Metabolite and Inhibitor of the NLRP3 Inflammasome: 4-hydroxynonenal

Jinmin Zhang, Bradford C Berk, Chia George Hsu

Journal of Cellular Immunology · 2024

DOI: 10.33696/immunology.6.192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Immunology, 2024. Verfasst von Jinmin Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome, crucial in the innate immune response, is linked to various human diseases. However, the effect of endogenous metabolites, like 4-hydroxynonenal (HNE), on NLRP3 inflammasome activity remains underexplored. Recent research highlights HNE's inhibitory role in NLRP3 inflammasome activation, shedding light on its potential as an endogenous regulator of inflammatory responses. Studies demonstrate that HNE blocks NLRP3 inflammasome-mediated pyroptosis and IL-1β secretion. Additionally, covalent targeting emerges as a common mechanism for inhibiting NLRP3 inflammasome assembly, offering promising avenues for therapeutic intervention. Further investigation is needed to understand the impact of endogenous HNE on NLRP3 inflammasome activation, especially in settings where lipid peroxidation byproducts like HNE are produced. Understanding the intricate interplay between HNE and the NLRP3 inflammasome holds significant potential for unraveling novel therapeutic strategies for inflammatory disorders.

Schlagwörter

Stichwörter der Autor:innen

4-hydroxynonenalInflammationMacrophageNLRP3Pyroptosis

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA.
  • Department of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
  • Department of Physical Medicine and Rehabilitation, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
  • Department of Kinesiology, The University of Texas at San Antonio, San Antonio, TX, USA.

Förderung

  • NIEHS NIH HHS

Zitieren

APA

Zhang, J., Berk, B. C., & Hsu, C. G. (2024). A Natural Metabolite and Inhibitor of the NLRP3 Inflammasome: 4-hydroxynonenal. Journal of Cellular Immunology. https://doi.org/10.33696/immunology.6.192

Vancouver

Zhang J, Berk BC, Hsu CG. A Natural Metabolite and Inhibitor of the NLRP3 Inflammasome: 4-hydroxynonenal. Journal of Cellular Immunology. 2024. doi:10.33696/immunology.6.192

BibTeX
@article{Zhang2024,
  author = {Zhang, Jinmin and Berk, Bradford C and Hsu, Chia George},
  title = {A Natural Metabolite and Inhibitor of the NLRP3 Inflammasome: 4-hydroxynonenal},
  journal = {Journal of Cellular Immunology},
  year = {2024},
  doi = {10.33696/immunology.6.192}
}
Kostenlos starten →